Research Development in Patients with Olmsted Syndrome / 罕见病研究
JOURNAL OF RARE DISEASES
; (4): 164-169, 2023.
Article
em Zh
| WPRIM
| ID: wpr-1005071
Biblioteca responsável:
WPRO
ABSTRACT
Olmsted syndrome (OS) is an extremely rare hereditary skin disease, that is usually characterized by mutilating palmoplantar keratoderma (PPK) and periorificial keratotic plaques. The diagnosis of this disease depends primarily on the clinical presentation and OS has to be differentiated from other disorders associated with hyperkeratosis. In recent years, there have been many advances in molecular genetic research on the pathogenesis of the disease. The genes that can cause disease after specific mutations include TRPV3, MBTPS2/S2P and PERP. Therefore, genetic testing has become one of the important methods for the diagnosis of this disease.OS treatment is difficult, and conventional therapy uses topical drugs to soften the cuticle of the skin, or oral Avi A.Excision of palmoplantar keratosis may also be used for constricting rings that severely restrict movement, but they often reoccur after initial improvement. In terms of precision treatment, researchers have tried the small molecule drugs erlotinib and sirolimus and have achieved some results. This paper summarizes the etiology, pathogenesis, clinical manifestations, diagnosis, treatment and prognosis of OS, in order to improve the clinicans' awareness of OS.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
JOURNAL OF RARE DISEASES
Ano de publicação:
2023
Tipo de documento:
Article